To rapidly monitor the emergence of new COVID-19 viral strains and evaluate their impact on vaccine candidates in develo...
Pfizer Inc. and BioNTech have announced that, after conducting the final efficacy analysis in their ongoing Ph...
US-based Cytiva, a global life sciences leader, is supporting Shanghai-based Clover Biopharmaceuticals, a global clinica...
The Australian government has announced that the largest flu vaccine manufacturing plant in the southern hemisphere will...
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and GL Rapha, one of the leading South ...
Arcturus Therapeutics Holdings Inc., based in the US, has announced positive interim clinical study results from its ong...
Pfizer Inc. and BioNTech SE have announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV...
Two more COVID-19 vaccines have been secured for the Australian population under new agreements, bringing the Australian...
On 1 Nov 2020, Australia reported the highest recorded childhood vaccination, with new figures showing four quarters of ...
Takeda Pharmaceutical has announced that it will import and distribute 50 million doses of Moderna’s COVID-19...
Moderna Inc. has announced a supply agreement with the Ministry of Public Health of Qatar for mRNA-1273, Moder...
The Russian Direct Investment Fund, (RDIF, Russia's sovereign wealth fund), has submitted applications to...
The global effort to ensure equitable global access to COVID-19 vaccines received a boost with the announcement of a maj...
Pfizer Inc. and BioNTech SE on 21 Oct 2020 announced the start of a Phase 1/2 study in Japan for their BN...
Thailand Ministry of Public Health, Siam Bioscience, SCG and British-Swedish biopharmaceutical company AstraZeneca has s...
Taiwan based TTY Biopharm Company, has announced that it has received authorization for the delivery of coronavirus vacc...
A further collaboration among the Serum Institute of India (SII), the world’s largest vaccine manufacturer by volu...
Johnson & Johnson on 8 Oct 2020 announced that the European Commission (EC), acting on behalf of the Europea...
The Coalition for Epidemic Preparedness Innovations (CEPI) in Norway has announced partnerships with five clinical sampl...
The Australian Government is investing a total of $2.3 billion to support home-grown researchers and manufacturers to de...
The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and one of the leading pharmaceutical d...
COVAXX, a subsidiary of United Biomedical Inc (UBI) headquartered in the US, has announced the first healthy a...
Johnson & Johnson has announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for i...
The Australian Government has joined the COVAX facility, enabling the purchase of COVID-19 vaccine doses as they become ...
Researchers from Monash University in Australia and the National University of Singapore have adapted new cancer and pan...
Australia will invest almost $6 million in additional funding from the Medical Research Future Fund’s (MRFF) Coron...
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases,&n...
Vaxess Technologies, an innovative biotechnology company in the US developing the MIMIX smart release patch, has formed ...
Oxford university and AstraZeneca are to resume the international clinical trial of their proposed coronavirus vaccine c...
INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect peop...
Intravacc, a global leader in translational research and development of viral and bacterial vaccines in the Netherlands,...
A free COVID-19 vaccine will be available progressively throughout 2021 in Australia, if promising trials prove successf...
AstraZeneca’s COVID-19 vaccine candidate, AZD1222, as a potential candidate for an emergency use authorization (EU...
Korea's LSK Global PS, a leading CRO to run Sinovac Phase III COVID-19 vaccine trial in Bangladesh. The company would m...
Beximco Pharmaceuticals Limited (BPL) in Bangladesh and the Serum Institute of India Pvt. Ltd (SII), have announced an a...
On 25 August 2020, Indian Health Ministery announced that a dialogue has been exchanged between India and Russia on...
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, has announced it has signed two agreeme...
For the first time ever, Taiwan's Food and Drug Administration (FDA) has given conditional approval for the experimental...
Australia has inked an agreement with British pharmaceutical giant AstraZeneca to supply Australians with the ...
Japan's FUJIFILM Diosynth Biotechnologies, world-leading contract development and manufacturing organization (CDMO) for ...
China's CanSino Biologics Inc. announced on 13 August 2020 that it has successfully listed on the Sci-Tech Innovati...
Australia is progressing with its new and improved Q Fever vaccine at pre-clinical trials following a $1.87 million inje...
The world’s first Phase III trials of an inactivated vaccine for COVID-19 being held in the United Arab Emirates h...
AstraZeneca signed a deal with Beijing-based Shenzhen Kangtai Biological Products (BioKangtai) ...
Johnson & Johnson on 5 August 2020 announced it's Janssen Pharmaceutical Companies have entered into an agreeme...
Vaccine manufacturers seeking listing on the National Immunisation Program (NIP) Schedule must ask for advice from ...
American multinational corporation Johnson & Johnson (J&J) has announced that its lead vaccine candidate pr...
Pfizer Inc. and BioNTech SE have announced an agreement with the Ministry of Health, Labour and Welfare (MHLW) in Japan ...
The two leading vaccine candidates CanSinoBIO of China and AZD1222 of UK have proven the safety and efficacy a...
The next critical phase for Australia's University of Queensland’s COVID-19 vaccine is underway – with the r...
CanSino Biologics Inc., an innovative biopharmaceutical company dedicated to vaccine R&D and commercialization, has ...
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has announced that its subsidiary Shanghai Fosun Pharmaceutical Industri...
Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) th...
The Osaka-based Japanese biotech AnGes Inc. expects its potential COVID-19 vaccine to be ready as early as the first hal...
The Phase I/II clinical trials of the world's first inactivated COVID-19 vaccine, developed by Wuhan Institute of Biolog...
South Korea based Genexine has announced that it is the first domestic pharmaceutical company to have been approved for ...
Ten COVID-19 vaccine candidates are currently in clinical trials (as of 4 June). These are listed in the below, in appro...
Clover Biopharmaceuticals, headquartered in China, has announced that the first participants have been dosed in the Phas...
Daiichi Sankyo Company, Limited has announced its decision to develop a genetic (mRNA) vaccine for the novel corona viru...
Serum Institute of India (SII) is the world’s largest vaccine producer in terms of volume. SII is currently workin...
In collaboration with the International Pharmaceutical Students’ Federation’s (IPSF) and the International F...
China-based Sinovac Biotech Ltd. inked a clinical development collaboration agreement with a Brazilian producer of immun...
Gernam firm BioNTech SE closed USD112.55 million debt financing agreement to support the development of the company&rsqu...
Moderna, Inc. announced on 11 June 2020 about progress on the late-stage development of mRNA-1273, the Company&rsqu...
Heat degradation of the proteins in vaccines render these expensive and precious biomedical products ineffective. Scient...
A recent Phase I clinical trial performed at the University Medical Center Hamburg-Eppendorf for a Middle East respirato...
UK-based AstraZeneca and the University of Oxford partnered on the global development and distribution ...
Novavax commenced Phase I clinical trial for their COVID-19 vaccine "NVX-CoV2373" a stable prefusion protein antige...
US based INOVIO, the International Vaccine Institute (IVI), and Seoul National University Hospital have announ...
CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland (UQ) have announced that...
The Coalition for Epidemic Preparedness Innovations (CEPI) on 3 June 2020 announced a new partnering agreement to advanc...
Chikungunya is considered to be a major public health threat by the World Health Organization. A speciality vaccine...
Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to creat...
US based Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines...
The Netherlands-based Intravacc, one of the world's leading translational research and development vaccine ins...
Merck, known as MSD outside the United States and Canada, and IAVI, a nonprofit scientific research organization dedicat...
US based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious di...
Vaxine Pty Ltd., Adelaide, Australia announced that it has entered into a formal collaboration with Medytox Inc., a Kore...
US based PharmaJet®, the maker of innovative, needle-free injection technology, has announced that its Needle-free I...
Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, has announced a transaction in which Ad...
Denmark headquartered AGC Biologics, a global Contract Development and Manufacturing Organization (CDMO) for Biopharmace...
US based Moderna, Inc., a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines...
Transgene, a biotech company in Tokyo that designs and develops virus-based immunotherapies for the treatment of cancer,...
US based Moderna, Inc., a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines...
Pfizer Inc. and BioNTech SE announced on 5 May 2020 that the first participants have been dosed in the U.S. in the...
Norway based CEPI, the Coalition for Epidemic Preparedness Innovations has announced a ninth worldwide collaboration to ...
Novel Coronavirus presents a global pandemic with unprecedented medical, economic and social scales. Since there is curr...
China’s CanSino Biologics advancing its SARS-CoV-2 vaccine to a Phase II clinical trial making this vaccine c...
Japan based NEC Corporation has announced analysis results from efforts using AI prediction platforms to design blueprin...
South Korea based International Vaccine Institute (IVI) has announced that the Coalition for Epidemic Preparedness Innov...
According to the latest news from Science and Technology Daily, two COVID-19 inactivated vaccines were just approved f...
Indian Immunologicals Limited (IIL), a leading vaccines manufacturing company, has announced that the company is going t...
The Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national science agency, has...
Medicago, a biopharmaceutical company headquartered in Quebec City, Canada has announced that they have successfully pro...
Novavax and Serum Institute of India (SII) has announced a commercial license agreement for the use of Novavax’ pr...
CEPI, the Coalition for Epidemic Preparedness Innovations, on 10 March 2020 announced the expansion of its COVID-19 vacc...
Serum Institute of India Pvt. Ltd. (SIIPL), the world's largest vaccine manufacturer by number of doses produced and sol...
Scientists from the National University of Singapore (NUS) community are working on a vaccine trial and rapid detection ...
WuXi Vaccines, a new vaccine Contract Development and Manufacturing Organization (CDMO) established between WuXi Biologi...
Pfizer Inc. has announced the launch of its Vaccines Division’s Centers of Excellence Network, a global program of...
